Earnings Call · Q4 FY2021·2022-02-25

Q4 21EPS -47.55%·Rev n/aQ3 21EPS -9.58%·Rev n/aQ2 21EPS -18.75%·Rev n/aQ1 21EPS -49.29%·Rev n/a⚠ consensus missing

Biohaven Ltd. BHVN

Caroline Dircks — Investor Relations

Vlad Coric — Chief Executive Officer

Matthew Buten — Chief Financial Officer

BJ Jones — Chief Commercial Officer

Unidentified Company Representative — Patient/Testimonial Speaker

Elyse Stock — Chief Medical Officer

Michael Bozik — Executive (Kv7 platform founder, joining Biohaven Labs)

Steven Dworetzky — Executive (joining Biohaven Labs)

Cliff Bechtold — Executive (Portfolio management, anti-myostatin inhibitor)

Research tier

Behavioral profile computed for 9 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BHVN calls or request research access.

More BHVN calls Browse calls Request research access